Israel - Hebräisch - Ministry of Health

devries & co. ltd - betamethasone - טבליה - betamethasone 0.5 mg - betamethasone - betamethasone - diseases responsive to oral glucocorticosteroid therapy.

Israel - Hebräisch - Ministry of Health

rafa laboratories ltd - betahistine hydrochloride - טבליה - betahistine hydrochloride 16 mg - betahistine - betahistine - meniere`s syndrome. symptomatic treatment of peripheral vertigo.

Israel - Hebräisch - Ministry of Health

abic marketing ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

Israel - Hebräisch - Ministry of Health

organon pharma israel ltd., israel - follitropin beta - תמיסה להזרקה - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.

Israel - Hebräisch - Ministry of Health

medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

Israel - Hebräisch - Ministry of Health

novartis israel ltd - betamethasone as dipropionate; calcipotriol as monohydrate - משחה - betamethasone as dipropionate 0.50 mg/g; calcipotriol as monohydrate 0.050 mg/g - betamethasone

Israel - Hebräisch - Ministry of Health

medison pharma ltd - betaine anhydrous - אבקה להכנת תמיסה - betaine anhydrous 1 g/g - betaine

Israel - Hebräisch - Ministry of Health

medison pharma ltd - betaine anhydrous - אבקה להכנת תמיסה - betaine anhydrous 1 g/g - betaine

Israel - Hebräisch - Ministry of Health

medison pharma ltd - betaine anhydrous - אבקה להכנת תמיסה - betaine anhydrous 1 g/g - betaine

Israel - Hebräisch - Ministry of Health

glaxo smith kline (israel) ltd - belantamab mafodotin - אבקה להכנת תמיסה מרוכזת לעירוי - belantamab mafodotin 100 mg - belantamab